The Mesothelioma Guide Blog

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...

Treatment for peritoneal mesothelioma is today where treatment was three years ago for pleural mesothelioma. Tumor treating fields are not yet acceptable for non-surgical cases....

There are various types of immunotherapy. Could pairing two of them work for malignant mesothelioma? A new study out of the National Cancer Institute is combining an immune...

The next chapter in the Johnson & Johnson asbestos saga is almost written. It might be defined by one word: bankruptcy. According to reports from the Wall Street Journal and...

Immunotherapy and radiation therapy may have a synergistic effect on one another. For people with malignant mesothelioma, this is a source of hope. Two new clinical trials are...

Is “SMART” the smartest way to treat mesothelioma? Or could we make it … “smarter”? Since its inception at Princess Margaret Cancer Center in Toronto, Canada, the SMART...

The COVID‑19 coronavirus pandemic put a lot of clinical trials on hold due to limitations and reservations regarding on‑site cancer treatment. This was bad news in the efforts...

Most people with mesothelioma either don’t respond to first‑line chemotherapy or respond temporarily, only for the tumors to continue spreading after a brief halt. Relapsed...

Malignant mesothelioma usually singles out elderly people, but in rare instances, young adults or even kids may develop the cancer. It’s a heartbreaking diagnosis for someone so...